TU Dresden

Widespread disease diabetes: Why do beta cells refuse to release insulin?
New insights into the "teamwork" of cells: Super-connected "leader" cells coordinate insulin response and help us to understand how diabetes develops One in eleven adults... [read more]
The study of Imperial College London and TU Dresden / CRTD scientists and colleagues from other research institutes from the UK, Canada and Italy is featured on the cover of the scientific journal Nature Metabolism
Rise and shine to science
CRTD, B CUBE and BIOTEC welcomed more than 2,000 visitors to the 17th Dresden Science Night [read more]
Dresden Science Night © Friederike Braun
CRTD researchers bring innovation from bench to bedside
Novel process for the production of suppressive T cells The Center for Regenerative Therapies (CRTD) at the TU Dresden and the University Hospital Carl Gustav Carus have successfully... [read more]
The Good Manufacturing Practice (GMP) Facility of the CRTD © CRTD
How fish brain cells react to Alzheimer’s disease
Zebrafish, in contrast to humans, have outstanding regenerative capacities: If brain cells are lost due to illness or injury, they will easily regrow from so-called progenitor cells. With... [read more]
© Caghan Kizil / DZNE
What happens in the body of ALS patients?
Scientists from TU Dresden find ways to reduce the number of dying neurons and search for therapeutic approaches to treat ALS   Amyotrophic lateral sclerosis (ALS) is an incurable... [read more]
Registration open for the 13th CRTD Summer Conference
Register now and save the date [read more]
© Thomas Schlorke
Girls' Day 2019
Future prospects for girls at the CRTD and the fascinating, regenerating zebrafish. [read more]
CRTD research featured on the cover of EMBO Journal is highlighted by the scientific community
The group of Prof. Federico Calegari shows that boosting stem cells gives extra neurons to the brain and turns ordinary mice into “super-smellers”. [read more]
Cover of EMBO Journal

Research at the Center for Regenerative Therapies (CRTD) at TU Dresden focuses on discovering principles of cell and tissue regeneration, and leveraging this for recognition, treatment, and reversal of diseases. The CRTD is well positioned for this challenge with its diversity in model organisms, organs, and disease systems and its range of methodological approaches from basic research to validation projects and clinical studies. The CRTD links the bench to the clinic, and scientists to clinicians to bring expertise in stem cells, gene-editing, and regeneration towards innovative therapies for metabolic, osteo-hematological, and neurological diseases.